Matches in SemOpenAlex for { <https://semopenalex.org/work/W1961039296> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W1961039296 endingPage "664" @default.
- W1961039296 startingPage "657" @default.
- W1961039296 abstract "Coadministration of intravenous (IV) iron improves responses to erythropoiesis-stimulating agents (ESAs) in the treatment of cancer-associated (CAA) and chemotherapy-induced anemia (CIA). Twelve prospective studies have demonstrated synergy between parenteral iron and ESAs, with variable degrees of improved hemoglobin (Hgb) response rates, shorter times to target Hgb levels, and a lower ESA dose required for equivalent Hgb responses. Clinically significant adverse events (AEs) with currently available IV iron products are uncommon. Pretreatment serum hepcidin levels may predict response magnitude. Safety concerns among many oncologists are driven by reports of serious AEs from older IV iron formulations that are no longer available, and misinterpretation of the nature and frequency of minor infusion reactions. Premedication with antihistamines is of unproven benefit and can cause symptoms that mimic anaphylaxis, prompting intervention with vasopressors and converting self-limited reactions into hemodynamically significant AEs. Payer rules proscribing the administration of ESAs and IV iron on the same day also have limited the clinical adoption of IV iron and ESA coadministration. At a time when financial resources are scarce, the ability to reduce use of costly ESAs is beneficial. Despite a favorable risk/benefit ratio for IV iron in CAA and CIA, current IV iron recommendations in guidelines from ASCO/ASH, NCCN, and ESMO are inconsistent. The authors believe more routine use of IV iron for CAA and CIA is appropriate in view of existing evidence, and suggest reconsideration of the current ASCO/ASH guidelines, which state “there is insufficient evidence to consider the use of intravenous iron as a standard of care.”" @default.
- W1961039296 created "2016-06-24" @default.
- W1961039296 creator A5057509756 @default.
- W1961039296 creator A5059876271 @default.
- W1961039296 creator A5090527595 @default.
- W1961039296 date "2014-05-01" @default.
- W1961039296 modified "2023-10-03" @default.
- W1961039296 title "Should the ASCO/ASH Guidelines for the Use of Intravenous Iron in Cancer- and Chemotherapy-Induced Anemia Be Updated?" @default.
- W1961039296 doi "https://doi.org/10.6004/jnccn.2014.0069" @default.
- W1961039296 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24812134" @default.
- W1961039296 hasPublicationYear "2014" @default.
- W1961039296 type Work @default.
- W1961039296 sameAs 1961039296 @default.
- W1961039296 citedByCount "14" @default.
- W1961039296 countsByYear W19610392962014 @default.
- W1961039296 countsByYear W19610392962015 @default.
- W1961039296 countsByYear W19610392962016 @default.
- W1961039296 countsByYear W19610392962017 @default.
- W1961039296 countsByYear W19610392962021 @default.
- W1961039296 countsByYear W19610392962023 @default.
- W1961039296 crossrefType "journal-article" @default.
- W1961039296 hasAuthorship W1961039296A5057509756 @default.
- W1961039296 hasAuthorship W1961039296A5059876271 @default.
- W1961039296 hasAuthorship W1961039296A5090527595 @default.
- W1961039296 hasBestOaLocation W19610392961 @default.
- W1961039296 hasConcept C121608353 @default.
- W1961039296 hasConcept C126322002 @default.
- W1961039296 hasConcept C177713679 @default.
- W1961039296 hasConcept C197934379 @default.
- W1961039296 hasConcept C203014093 @default.
- W1961039296 hasConcept C207480886 @default.
- W1961039296 hasConcept C2775933838 @default.
- W1961039296 hasConcept C2776694085 @default.
- W1961039296 hasConcept C2777417653 @default.
- W1961039296 hasConcept C2778248108 @default.
- W1961039296 hasConcept C2778300832 @default.
- W1961039296 hasConcept C2778917026 @default.
- W1961039296 hasConcept C3020614022 @default.
- W1961039296 hasConcept C42219234 @default.
- W1961039296 hasConcept C71924100 @default.
- W1961039296 hasConceptScore W1961039296C121608353 @default.
- W1961039296 hasConceptScore W1961039296C126322002 @default.
- W1961039296 hasConceptScore W1961039296C177713679 @default.
- W1961039296 hasConceptScore W1961039296C197934379 @default.
- W1961039296 hasConceptScore W1961039296C203014093 @default.
- W1961039296 hasConceptScore W1961039296C207480886 @default.
- W1961039296 hasConceptScore W1961039296C2775933838 @default.
- W1961039296 hasConceptScore W1961039296C2776694085 @default.
- W1961039296 hasConceptScore W1961039296C2777417653 @default.
- W1961039296 hasConceptScore W1961039296C2778248108 @default.
- W1961039296 hasConceptScore W1961039296C2778300832 @default.
- W1961039296 hasConceptScore W1961039296C2778917026 @default.
- W1961039296 hasConceptScore W1961039296C3020614022 @default.
- W1961039296 hasConceptScore W1961039296C42219234 @default.
- W1961039296 hasConceptScore W1961039296C71924100 @default.
- W1961039296 hasIssue "5" @default.
- W1961039296 hasLocation W19610392961 @default.
- W1961039296 hasLocation W19610392962 @default.
- W1961039296 hasOpenAccess W1961039296 @default.
- W1961039296 hasPrimaryLocation W19610392961 @default.
- W1961039296 hasRelatedWork W1980882008 @default.
- W1961039296 hasRelatedWork W2092371439 @default.
- W1961039296 hasRelatedWork W22040025 @default.
- W1961039296 hasRelatedWork W2205873021 @default.
- W1961039296 hasRelatedWork W2219358559 @default.
- W1961039296 hasRelatedWork W2358410098 @default.
- W1961039296 hasRelatedWork W2364664635 @default.
- W1961039296 hasRelatedWork W2765128801 @default.
- W1961039296 hasRelatedWork W3031844403 @default.
- W1961039296 hasRelatedWork W4367315080 @default.
- W1961039296 hasVolume "12" @default.
- W1961039296 isParatext "false" @default.
- W1961039296 isRetracted "false" @default.
- W1961039296 magId "1961039296" @default.
- W1961039296 workType "article" @default.